The doxycycline paradox in mitochondrial disease
Release Date:
Expanding on their recent editorial, Shamima Rahman, Eva Morava and Tamas Kozicz discuss the doxycycline paradox and why a medication previously thought to be toxic might present an avenue for treatment in some primary mitochondrial disorders.
The doxycycline paradox in primary mitochondrial diseases
Tamas Kozicz, Shamima Rahman, and Eva Morava
https://doi.org/10.1002/jimd.12531
The doxycycline paradox in mitochondrial disease